Evidence map›Paper›PMID 42252711›Full record

ArticleThe plant pathology journal2026

Enhanced Control of Pepper Anthracnose through Co-Application of Paenibacillus polymyxa GYUN-2285 and Pseudomonas protegens GYUN-2679.

Rosa Jang, Heejin Kim, Jungyeon Kim, Yongho Jeon

Abstract read
In one paragraph

Article in The plant pathology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rosa JangMajor in Plant Medicals, School of Smart Green Technology, Gyeongkuk National University, Andong 36729, Korea.
Heejin KimMajor in Plant Medicals, School of Smart Green Technology, Gyeongkuk National University, Andong 36729, Korea.
Jungyeon KimMajor in Plant Medicals, School of Smart Green Technology, Gyeongkuk National University, Andong 36729, Korea.
Yongho JeonMajor in Plant Medicals, School of Smart Green Technology, Gyeongkuk National University, Andong 36729, Korea. yongbac@gknu.ac.kr.

Funding

Gyeongkuk National University
6 · The paper itself

Abstract

Anthracnose disease caused by Colletotrichum species is one of the most economically important, frequently leading to substantial yield and quality losses. This study investigated the biocontrol potential of two rhizosphere-associated bacteria, Paenibacillus polymyxa GYUN-2285 and Pseudomonas protegens GYUN-2679 isolated from soil. GYUN-2285 and GYUN-2679 were evaluated separately, and the two strains were subsequently co-applied to examine whether their combined treatment improved pathogen suppression relative to individual applications. Dual culture assays showed that both strains inhibited a broad range of plant pathogenic fungi, including several Colletotrichum species. The combined application of the two strains significantly promoted plant growth, enhancing seedling vigor and development. In planta experiments on pepper fruits revealed that individual applications GYUN-2285 and GYUN-2679 significantly reduced disease serverity. Notably, the combined treatment showed greater numerical suppression than the individual treatments under the tested conditions. This improved performance may be associated with the complementary functional traits of the two bacteria, which may broaden their antagonistic activity against pathogens. These findings suggest that the integration of GYUN-2285 and GYUN-2679 into biocontrol strategies offers a promising, sustainable, and eco-friendly alternative for managing anthracnose in peppers.

Indexed as

anthracnosebiological controlColletotrichumPaenibacillus polymyxaPseudomonas protegens

Identifiers

PMID42252711
PMCPMC13243907

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.